Home
Browse
Prime browse
Clustered VIS browse
Search
Curation
Gene
Target gene
All
Oncogene
Tumor suppressor gene
Nearby gene
All
Oncogene
Tumor suppressor gene
MicroRNA
RNA-interaction
ncRNA
Host2Host
Host2Virus
Virus2Host
• miRNA
Host2Host
Host2Virus
Virus2Host
• lncRNA
Host2Host
Host2Virus
Virus2Host
Download
Statistics
Help
VISDB
Viral Integration Site DataBase
Homepage
Prime VIS Browse Options
TVIS30012146
Basic Information
VIS ID
TVIS30012146
Fusion event
HIV-DYNC1LI2 integration
Validated
No
Detection method
QiaQuick PCR and Sequencing
Data source
download(RID)
Sample type
Cell line
Disease
HIV-infected disease (HID)
Quality evaluation
Normal
Reported year
2013
PubMed ID
23953889
Virus Sequence
Virus name
HIV
Reference genome
Not given
Host Sequence
Chromosome
chr16
Cytoband
q22.1
Reference genome
GRCh37/hg19
Start
66782747/66748844 (Hg38)
End
66782747/66748844 (Hg38)
Orient
+
Location type
Intronic
Fragile sites / regions
FRA16B
Target gene
DYNC1LI2
miRNAs that regulate target gene
hsa-mir-21-5p
;
hsa-let-7f-5p
;
hsa-mir-3676-3p
;
hsa-mir-548a-3p
;
hsa-mir-548e-3p
;
hsa-mir-548f-3p
;
hsa-mir-548ar-3p
;
hsa-mir-548az-3p
;
hsa-mir-3148
;
hsa-mir-183-3p
;
hsa-mir-20a-5p
;
hsa-mir-106b-5p
;
hsa-mir-4680-3p
;
hsa-mir-1285-5p
;
hsa-mir-651-3p
;
hsa-mir-548x-3p
;
hsa-mir-548j-3p
;
hsa-mir-548aq-3p
;
hsa-mir-548am-3p
;
hsa-mir-548aj-3p
;
hsa-mir-548ah-3p
;
hsa-mir-548ae-3p
;
hsa-mir-759
;
hsa-mir-3613-3p
;
hsa-mir-519c-3p
;
hsa-mir-519b-3p
;
hsa-mir-519a-3p
;
hsa-mir-19a-3p
;
hsa-mir-19b-3p
;
hsa-mir-93-5p
;
hsa-mir-519d-3p
;
hsa-mir-20b-5p
;
hsa-mir-17-5p
;
hsa-mir-106a-5p
;
hsa-mir-526b-3p
;
hsa-mir-301b-3p
;
hsa-mir-3666
;
hsa-mir-130a-3p
;
hsa-mir-4295
;
hsa-mir-301a-3p
;
hsa-mir-454-3p
;
hsa-mir-130b-3p
;
hsa-mir-181d-5p
;
hsa-mir-181c-5p
;
hsa-mir-181a-5p
;
hsa-mir-181b-5p
;
hsa-mir-101-3p
;
hsa-mir-1827
;
hsa-mir-25-3p
;
hsa-mir-3160-3p
;
hsa-mir-32-5p
;
hsa-mir-34b-3p
;
hsa-mir-3614-5p
;
hsa-mir-363-3p
;
hsa-mir-3664-3p
;
hsa-mir-367-3p
;
hsa-mir-3689d
;
hsa-mir-3929
;
hsa-mir-425-3p
;
hsa-mir-4419b
;
hsa-mir-4433a-3p
;
hsa-mir-4452
;
hsa-mir-4459
;
hsa-mir-4478
;
hsa-mir-4487
;
hsa-mir-4649-3p
;
hsa-mir-4695-5p
;
hsa-mir-4722-5p
;
hsa-mir-4768-3p
;
hsa-mir-485-5p
;
hsa-mir-500a-3p
;
hsa-mir-510-5p
;
hsa-mir-5186
;
hsa-mir-558
;
hsa-mir-582-5p
;
hsa-mir-6134
;
hsa-mir-6500-3p
;
hsa-mir-655-5p
;
hsa-mir-665
;
hsa-mir-6746-5p
;
hsa-mir-6771-5p
;
hsa-mir-6799-5p
;
hsa-mir-6808-5p
;
hsa-mir-6851-5p
;
hsa-mir-6880-5p
;
hsa-mir-6884-5p
;
hsa-mir-6893-5p
;
hsa-mir-7160-5p
;
hsa-mir-767-5p
;
hsa-mir-7703
;
hsa-mir-7847-3p
;
hsa-mir-92a-3p
;
hsa-mir-92b-3p
;
hsa-mir-940
Nearest miRNA
hsa-mir-1225/Upstream/8976492; hsa-mir-11401/Downstream/453477;
Nearest TSS
ENST00000527434/Upstream/10581;
ENST00000501143/Downstream/2750;
Nearest CpG islands
None/Target,
chr16-CpG: 29/Upstream/51485
,
chr16-CpG: 83/Downstream/2293
Upstream sequence
ACTGTCACAAAGAGATTCAGGAAACTCTCCTATTAACATATGTTAAATTGTTACACTCTAAACCACACCAACTTCGGATTCTCTACTAGAACCAGGCAGA
Downstream sequence
GTAACAATGGTCCCCAGGACAGCCAAGCATTTCTCTCATATAAAACTCCAAAGCTTTAAAAAATCTTTCTTACCACCTTTATGGGTTAAGTAAAAATTTA
Reference
Sherrill-Mix, S., et al. HIV latency and integration site placement in five cell-based models.2013, Retrovirology 10: 90.
Sample Information
×
Sample name
Resting CD4+
Sample type
Cell line
Gender
Female
CpG Island Information
×
Download
Curate